Inhibition of Puerperal Lactation: A Double Blind Study of Bromocriptine and Placebo

References

• Walker S., Groom G., Hibbard B. M., Griffiths K., Davis R. H. Controlled trial of Bromocriptine quinestrol and placebo in suppression of puerperal lactation. Lancet 1975; 2: 842
   Google Scholar
• Seppala M., Ylinen O., Sternthal V., Soiva K., Vara P. Suppression of established puerperal lactation with 2-BR-alpha-ergocryptine methane sulpho-nate (CB 154). Int J Gynaecol Obstet 1975; 13: 1
   Google Scholar
• Falzon M. D., Galea R., Camilleri A. P. An ergocryptine as a lactation inhibitor. Gynaecol Invest 1974; 5: 133
   Google Scholar
• Rolland R., Shellekens L. A new approach to the inhibition of puerperal lactation. J Obstet Gynaecol Br Comm 1973; 80: 945
   Google Scholar
• Varga L., Lutterbeck P. M., Pryor J. S., Wenner R., Erb H. Suppression of puerperal lactation with an ergot alkaloid; a double blind study. Br Med J 1972; 2: 743
   PubMed Web of Science ®Google Scholar
• Brun del R. E. R., del Pozo E., de Grandi P., Friesen H., Hinselmann M., Wyss H. Prolactin inhibition and suppression of puerperal lactation by a BR-ergocryptine (CB154); a comparison with estrogen. Obstet Gynaecol 1973; 41: 884
   Google Scholar
• Goebel R., Rjosk H. K., von Werder K. Concentration of prolactin and estrogens during suppression of puerperal lactation in humans. Acta Endocrinol (KBH) 1974; 113, Suppl. 184
   Google Scholar
• Varga L., Radielovic P. Postpartum lactation inhibition with 2-BR-alpha-ergocryptine. Geburtsh Frauenheilk 1974; 34: 882
   Google Scholar
• Editorial. Bromocriptine—a changing scene. Br Med J 1975; 4: 667
   Google Scholar
• Utian W. H., Begg G., Vinik A. I., Paul M., Shuman L. Effect of Bromocriptine and chlorotrianisine on inhibition of lactation and serum prolactin; a comparative double-blind study. Br J Obstet Gynaecol 1975; 82: 755
   Google Scholar
• Biswas S., Hindocha P., Dewhurst C. J. Human chorionic somato-mammotrophin in serum and urine in various stages of pregnancy; its correlation with enzymes and oestrogen. J Endocrinol 1972; 54: 251
   Google Scholar
• Biswas S., Norman A. P., Baffoe G., Grace L. Prolactin growth hormone and alphafeto protein in children with cystic fibrosis. Clin Chem Acta 1976, In press
   Google Scholar
• McNeilly A. S. Lactation and the physiology of prolactin secretion. Post-grad Med J 1975; 51: 231
   Google Scholar
• Thorner M. O. Dopamine is an important neuro transmitter in the autonomic nervous system. Lancet 1975; 1: 662
   PubMed Web of Science ®Google Scholar
• del Pozo E., Brun del R. E. R., Varga L., Friesen H. The inhibition of prolactin secretion in man by CB154. J Clin Endocrinol Metabol 1972; 35: 768
   PubMed Web of Science ®Google Scholar
• Hökfelt T., Fuxe K. Effects of prolactin and ergot alkaloids on the tubero-infundibular Dopamine (DA) neurones. Neuroendocrinology 1972; 9: 100
   PubMed Web of Science ®Google Scholar
• Pasteels J. L., Danquy A., Frerotte M., Ectors F. Inhibition de la sécrétion de prolactine par l'ergocornine et la 2-BR alpha-ergocryptine; action direct sur l'hypophyse en culture. Ann Endocrinol (Paris) 1971; 32: 188
   PubMedGoogle Scholar
• Bonnar J., Franklin M., Nott P. N., McNeilly A. S. Effect of breast feeding on pituitary ovarian function after childbirth. Br Med J 1975; 319: 82
   Google Scholar
• Varga L., Wenner R., del Pozo E. Treatment of galactorrhea-amenorrhea syndrome with BR-ergocryptine (CB154); restoration of ovulatory function and fertility. Am J Obstet Gynecol 1973; 117: 75
   Google Scholar
• Besser G. M., Parke L., Edwards C. R. W., Forsyth I. A., McNeilly A. S. Galactorrhea: successful treatment with reduction of plasma prolactin levels by brom ergocryptine. Br Med J 1972; 3: 669
   PubMed Web of Science ®Google Scholar
• Rolland R., Schellikens L. A., Leguin R. M. Successful treatment of galactorrhea and amenorrhea and subsequent restoration of ovarian function by a new ergot alkaloid, 2-brom alpha ergocryptine. Clin Endocrinol 1974; 3: 155
   PubMedGoogle Scholar
• Rolland R., de Jong F. H., Schellekens L. A., Leguin R. M. Part 2: A study during inhibition of lactation by bromergocryptine. Clin Endocrinol 1975; 4: 27
   PubMedGoogle Scholar